Bepridil
As of the edition of 20 October 2026, Bepridil is a small molecule: marketed, first approved in 1990 (US); no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1990
- Kind
- Small molecule
- Brand name
- Bepadin
- First approved
- 28 December 1990 (US)
- Approvals on record
- 7 in 2 regions
- Holder of the most recent approval
- Johnson & Johnson; 3 holders in all
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Medpointe Pharmaceuticals Medpointe Healthcare | Acquired holder | 2003 to now |
| Johnson & Johnson | Acquired holder | 2005 to now |
| Merck & Co. | Applicant |